Catabasis Pharmaceuticals Inc Stock Nasdaq
Equities
US14875P1075
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 579M |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | -101M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.82
x | P/E ratio 2025 * |
-5.36
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.7% |
Latest transcript on Catabasis Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 08-06-25 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 11-03-31 |
Chief Tech/Sci/R&D Officer | - | 22-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 13-12-31 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 19-01-03 |
Director/Board Member | 75 | 16-04-04 |
1st Jan change | Capi. | |
---|---|---|
-3.39% | 102B | |
+2.61% | 96.84B | |
-0.73% | 21.48B | |
-18.14% | 20.82B | |
-7.33% | 18.6B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B |